Nasim Dana, Golnaz Vaseghi, & shaghayegh haghjooy javanmard. (2019). PPAR γ agonist, pioglitazone, suppresses melanoma cancer in mice by inhibiting TLR4 signaling. Frontiers Media S.A..
Chicago Style (17th ed.) CitationNasim Dana, Golnaz Vaseghi, and shaghayegh haghjooy javanmard. PPAR γ Agonist, Pioglitazone, Suppresses Melanoma Cancer in Mice by Inhibiting TLR4 Signaling. Frontiers Media S.A., 2019.
MLA (9th ed.) CitationNasim Dana, et al. PPAR γ Agonist, Pioglitazone, Suppresses Melanoma Cancer in Mice by Inhibiting TLR4 Signaling. Frontiers Media S.A., 2019.
Warning: These citations may not always be 100% accurate.